Endogenous Endophthalmitis in the Inpatient Setting
Recruitment status was Recruiting
The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes|
- Positive intraocular infection [ Time Frame: 1 day ] [ Designated as safety issue: No ]
- Visual acuity [ Time Frame: 2 wk ] [ Designated as safety issue: No ]
|Study Start Date:||July 2010|
|Estimated Study Completion Date:||June 2013|
|Estimated Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|
Some patients admitted to the hospital have blood-borne infections. Occasionally, these blood infections can end up inside the eye and cause an infection inside the eye (called endogenous endophthalmitis).
Prior to modern and rapid treatment of systemic infections, the rate of endogenous endophthalmitis was reported to be 37% in 1982. By 1997, the rate was reported to be 2.8%. This study aims to determine the rate of endogenous endophthalmitis at Stanford Hospital in the modern medical era in that our rates may be different as those reported in the literature. This potential difference may be a reflection of treatment protocols and antibiotics currently in use at Stanford Hospital.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01323868
|Contact: Theodore Leng, MD||(650) 723-6995|
|United States, California|
|Stanford University School of Medicine||Recruiting|
|Stanford, California, United States, 94305|
|Contact: Theodore Leng, MD 650-723-6995|
|Principal Investigator: Theodore Leng|
|Principal Investigator:||Theodore Leng||Stanford University|